Additional References

Allison J; Stephens LA; Kay TW; Kurts C; Heath WR; Miller JF; Krummel MF. 1998. The threshold for autoimmune T cell killing is influenced by B7-1. Eur J Immunol 28(3):949-60. [PubMed: 9541590]  [MGI Ref ID J:134587]

Barouch-Bentov R; Lemmens EE; Hu J; Janssen EM; Droin NM; Song J; Schoenberger SP; Altman A. 2005. Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells. J Immunol 175(8):5126-34. [PubMed: 16210616]  [MGI Ref ID J:119122]

Behrens GM; Li M; Davey GM; Allison J; Flavell RA; Carbone FR; Heath WR. 2004. Helper requirements for generation of effector CTL to islet beta cell antigens. J Immunol 172(9):5420-6. [PubMed: 15100283]  [MGI Ref ID J:89639]

Benedict CA; Loewendorf A; Garcia Z; Blazar BR; Janssen EM. 2008. Dendritic Cell Programming by Cytomegalovirus Stunts Naive T Cell Responses via the PD-L1/PD-1 Pathway. J Immunol 180(7):4836-47. [PubMed: 18354207]  [MGI Ref ID J:133375]

Blazar BR; Carreno BM; Panoskaltsis-Mortari A; Carter L; Iwai Y; Yagita H; Nishimura H; Taylor PA. 2003. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism. J Immunol 171(3):1272-7. [PubMed: 12874215]  [MGI Ref ID J:120213]

Bluestone JA; McKenzie IF; Melvold RW; Ozato K; Sandrin MS; Sharrow SO; Sachs DH. 1984. Serological analysis of H-2 mutations using monoclonal antibodies. J Immunogenet 11(3-4):197-207. [PubMed: 6084033]  [MGI Ref ID J:98121]

Bolinger B; Krebs P; Tian Y; Engeler D; Scandella E; Miller S; Palmer DC; Restifo NP; Clavien PA; Ludewig B. 2008. Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. Blood 111(9):4588-95. [PubMed: 18195091]  [MGI Ref ID J:134363]

Brown GR; Thiele DL. 2000. Enhancement of MHC class I-stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II-stimulated alloresponses by TNF/TNFR2 interactions Eur J Immunol 30(10):2900-7. [PubMed: 11069072]  [MGI Ref ID J:65234]

Brown RE; Schellinck HM; Jagosh J. 1998. Behavioural studies of MHC-congenic mice. Genetica 104(3):249-57. [PubMed: 10386391]  [MGI Ref ID J:55290]

Carroll LS; Penn DJ; Potts WK. 2002. Discrimination of MHC-derived odors by untrained mice is consistent with divergence in peptide-binding region residues. Proc Natl Acad Sci U S A 99(4):2187-92. [PubMed: 11842193]  [MGI Ref ID J:74764]

Dyer CM; Zhan Y; Brady JL; Carbone FR; Smyth MJ; Lew AM. 2004. Unexpectedly, induction of cytotoxic T lymphocytes enhances the humoral response after DNA immunization. Blood 103(8):3073-5. [PubMed: 15070687]  [MGI Ref ID J:115473]

El-Hayek JM; Rogers TE; Brown GR. 2005. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD. J Leukoc Biol 78(4):1001-7. [PubMed: 16081594]  [MGI Ref ID J:101534]

Erlebacher A; Vencato D; Price KA; Zhang D; Glimcher LH. 2007. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 117(5):1399-411. [PubMed: 17446933]  [MGI Ref ID J:122071]

Graubert TA; DiPersio JF; Russell JH; Ley TJ. 1997. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 100(4):904-11. [PubMed: 9259590]  [MGI Ref ID J:42355]

Hammer GE; Gonzalez F; James E; Nolla H; Shastri N. 2007. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 8(1):101-8. [PubMed: 17128277]  [MGI Ref ID J:116606]

Hofling AA; Vogler C; Creer MH; Sands MS. 2003. Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease. Blood 101(5):2054-63. [PubMed: 12406886]  [MGI Ref ID J:109848]

Hogquist KA; Jameson SC; Heath WR; Howard JL; Bevan MJ; Carbone FR. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76(1):17-27. [PubMed: 8287475]  [MGI Ref ID J:92867]

Huygen K; Drowart A; Harboe M; ten Berg R; Cogniaux J; Van Vooren JP. 1993. Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG. Infect Immun 61(6):2687-93. [PubMed: 8500908]  [MGI Ref ID J:13022]

Kievits F; Lokhorst W; Ivanyi P. 1990. Abnormal anti-viral immune response in mice is corrected in HLA-B27.2-transgenic mice. Eur J Immunol 20(5):1189-92. [PubMed: 1694133]  [MGI Ref ID J:128764]

Kirberg J; Bosco N; Deloulme JC; Ceredig R; Agenes F. 2008. Peripheral T lymphocytes recirculating back into the thymus can mediate thymocyte positive selection. J Immunol 181(2):1207-14. [PubMed: 18606674]  [MGI Ref ID J:137464]

Klein J; Figueroa F; David CS. 1983. H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics 17(6):553-96. [PubMed: 6407984]  [MGI Ref ID J:7097]

Lamouse-Smith E; McCarthy SA. 1997. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype. Cell Immunol 179(2):107-15. [PubMed: 9268494]  [MGI Ref ID J:42696]

Le Borgne M; Etchart N; Goubier A; Lira SA; Sirard JC; van Rooijen N; Caux C; Ait-Yahia S; Vicari A; Kaiserlian D; Dubois B. 2006. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24(2):191-201. [PubMed: 16473831]  [MGI Ref ID J:113330]

Leibnitz RR; Lipsky PE; Thiele DL. 1995. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides. J Immunol 155(4):1784-95. [PubMed: 7636234]  [MGI Ref ID J:28656]

Ljunggren HG; Van Kaer L; Sabatine MS; Auchincloss H Jr; Tonegawa S; Ploegh HL. 1995. MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice. Int Immunol 7(6):975-84. [PubMed: 7577806]  [MGI Ref ID J:26520]

MGD Nomenclature Committee. 1995. :.  [MGI Ref ID J:23000]

Maeda Y; Reddy P; Lowler KP; Liu C; Bishop DK; Ferrara JL. 2005. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood 106(2):749-55. [PubMed: 15797996]  [MGI Ref ID J:107458]

McKenzie IF; Morgan GM; Blanden RV; Melvold R; Kohn H. 1977. Studies of H-2 mutations in C57BL/6 and BALB/c mice. Transplant Proc 9(1):551-3. [PubMed: 68588]  [MGI Ref ID J:109278]

Melvold RW; Wang K; Kohn HI. 1997. Histocompatibility gene mutation rates in the mouse: a 25-year review. Immunogenetics 47(1):44-54. [PubMed: 9382920]  [MGI Ref ID J:44711]

Miyada CG; Klofelt C; Reyes AA; McLaughlin-Taylor E; Wallace RB. 1985. Evidence that polymorphism in the murine major histocompatibility complex may be generated by the assortment of subgene sequences. Proc Natl Acad Sci U S A 82(9):2890-4. [PubMed: 2581256]  [MGI Ref ID J:109270]

Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ. 1996. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts. J Thorac Cardiovasc Surg 112(2):310-3. [PubMed: 8751496]  [MGI Ref ID J:35731]

Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH. 1996. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. J Immunol 156(7):2473-80. [PubMed: 8786307]  [MGI Ref ID J:31937]

Ohlemiller KK; Hennig AK; Lett JM; Heidbreder AF; Sands MS. 2002. Inner ear pathology in the mucopolysaccharidosis VII mouse. Hear Res 169(1-2):69-84. [PubMed: 12121741]  [MGI Ref ID J:108876]

Pease LR; Schulze DH; Pfaffenbach GM; Nathenson SG. 1983. Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the major histocompatibility complex. Proc Natl Acad Sci U S A 80(1):242-6. [PubMed: 6571997]  [MGI Ref ID J:109263]

Selvaggi G; Ricordi C; Podack ER; Inverardi L. 1996. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection. Transplantation 62(12):1912-5. [PubMed: 8990386]  [MGI Ref ID J:37400]

Serody JS; Burkett SE; Panoskaltsis-Mortari A; Ng-Cashin J; McMahon E; Matsushima GK; Lira SA; Cook DN; Blazar BR. 2000. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease Blood 96(9):2973-80. [PubMed: 11049973]  [MGI Ref ID J:65501]

Serody JS; Cook DN; Kirby SL; Reap E; Shea TC; Frelinger JA. 1999. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier. Blood 93(1):43-50. [PubMed: 9864144]  [MGI Ref ID J:51842]

Sheng B; Odebralski JM; Smith RT. 1998. All or none peripheral tolerance induction in H-Y antigen-specific TCR transgenic mice. Transpl Immunol 6(2):78-83. [PubMed: 9777695]  [MGI Ref ID J:127670]

Shresta S; Graubert TA; Thomas DA; Raptis SZ; Ley TJ. 1999. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity 10(5):595-605. [PubMed: 10367905]  [MGI Ref ID J:55398]

Shulz M; Schuurman HJ; Joergensen J; Steiner C; Meerloo T; Kagi D; Hengartner H; Schreier MH; Burki K; Ledermann B. 1995. Acute rejection of vascular heart allografts by perforin- deficient mice. Eur J Immunol 25(2):474-480. [PubMed: 7533086]  [MGI Ref ID J:23268]

Sim BC; Travers PJ; Gascoigne NR. 1997. V alpha 3.2 selection in MHC class I mutant mice: evidence for an alternate orientation of TCR-MHC class I interaction. J Immunol 159(7):3322-9. [PubMed: 9317130]  [MGI Ref ID J:127052]

Spielman J; Lee RK; Podack ER. 1998. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol 161(12):7063-70. [PubMed: 9862744]  [MGI Ref ID J:112121]

Zhan Y; Bourges D; Dromey JA; Harrison LC; Lew AM. 2007. The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells. Int Immunol 19(4):455-63. [PubMed: 17314081]  [MGI Ref ID J:119986]